Chordin-Like 2: A Possible Therapeutic Target for Gastric Cancer by Affecting Cell Cycle and Proliferation

Figure 3

The association of CHRDL2 expression and prognosis in patients with stomach cancer in the KM-plotter database. (a) CHRDL2 and OS in individuals with gastric cancer. (b) CHRDL2 and PFS correlation in patients with gastric cancer. (c) CHRDL2 and PPS correlation in patients with gastric cancer. (d) Correlation between prognosis of patients with HER-2-positive gastric cancer and CHRDL2 expression. (e) The significance of CHRDL2 and prognosis in female gastric cancer patients. (f) Correlation between CHRDL2 expression and prognosis of patients with gastric tubular adenocarcinoma.

(a)

(b)

(c)

(d)

(e)

(f)